UK Passes 50,000 Coronavirus Deaths, Government Figures Show
Published
| Last updated

More than 50,000 people in the UK have now died with coronavirus, according to government figures.
A further 595 deaths were confirmed today (Wednesday 11 November), bringing the country's total to 50,365.
BREAKING: The number of people who have died with #coronavirus in the UK has passed 50,000, according to government figures.
- SkyNews (@SkyNews) November 11, 2020
Sky's @ashishskynews says it's a "sobering reminder of exactly what the human cost of this pandemic is".
More here: https://t.co/bMM4Bmll02 pic.twitter.com/gU33DvjAHK
The UK is the first country in Europe to pass 50,000 deaths and only the fifth in the world to reach the grim landmark, along with the United States, Brazil, India and Mexico.
The daily death rate rose rapidly throughout October, but it is still well below the rate during the first peak in April, when almost 1,000 people a day were dying after contracting the disease.

A further 22,950 cases were confirmed today, with a total of 1.2 million recorded in the country since the pandemic began.
The government's chief scientific adviser, Sir Patrick Vallance, said back in March that keeping the number of deaths in the country below 20,000 would represent a 'good result'.
Speaking at a press conference on Monday, Boris Johnson said there 'is a long way before we have got this thing beat'.
He added: "The biggest mistake we could make now would be to slacken our resolve at such a critical moment."
"Anti-vax is total nonsense. You should definitely get a vaccine"
- BBC Politics (@BBCPolitics) November 11, 2020
Prime Minister Boris Johnson says "we are not out of the woods yet" as UK becomes first country in Europe to pass 50,000 coronavirus deathshttps://t.co/HmclsvD5y1 pic.twitter.com/vVCYgddRYO
The prime minister was speaking following the announcement that a Covid-19 vaccine was found to be 90 percent effective in clinical trials.
According to Pfizer and BioNTech, the jab has been tested out on 43,500 people in six countries, with no safety concerns detected - and only 94 people in the trial went on to develop Covid-19.
According to the results from the initial analysis, two doses three weeks apart are needed for it to be effective.
There is, however, no definitive answer on how long the immunity lasts.
Speaking about the breakthrough, Dr Albert Bourla, the chairman of Pfizer, said he hoped this would help bring about an end to the suffering being experienced around the world.
He said: "Today is a great day for science and humanity. The first set of results from our Phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine's ability to prevent Covid-19.
"With today's news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis.
"While we are all in the midst of a second wave and many of us in lockdown, we appreciate even more how important this milestone is on our path towards ending this pandemic and for all of us to regain a sense of normality."
Featured Image Credit: PA
Topics: UK News, Coronavirus